scholarly journals Mutations affecting neural survival in the zebrafish Danio rerio

Development ◽  
1996 ◽  
Vol 123 (1) ◽  
pp. 217-227 ◽  
Author(s):  
S. Abdelilah ◽  
E. Mountcastle-Shah ◽  
M. Harvey ◽  
L. Solnica-Krezel ◽  
A.F. Schier ◽  
...  

Programmed cell death is a prominent feature of normal animal development. During neurogenesis, naturally occurring cell death is a mechanism to eliminate neurons that fail to make appropriate connections. To prevent accidental cell death, mechanisms that trigger programmed cell death, as well as the genetic components of the cell death program, are tightly controlled. In a large-scale mutagenesis screen for embryonic lethal mutations in zebrafish Danio rerio we have found 481 mutations with a neural degeneration phenotype. Here, we present 50 mutations that fall into two classes (termed spacehead and fala-like) that are characterized by two main features: first, they appear to affect cell survival primarily within the neuroectodermal lineages during somitogenesis, and second, they show an altered brain morphology at or before 28 hours of development. Evidence for the specificity of cell death within the central nervous system comes from visual inspection of dying cells and analysis of DNA fragmentation, a process associated with apoptotic cell death. In mutants, the level of dying cells is significantly increased in brain and spinal cord. Furthermore, at the end of somitogenesis, the cell count of radial glia and trigeminal neurons is reduced in some mutants of the spacehead class. A variety of neurodegenerative disorders in mouse and humans have been associated with abnormal levels of programmed cell death within the central nervous system. The mutations presented here might provide a genetic framework to aid in the understanding of the etiology of degenerative and physiological disorders within the CNS and the activation of inappropriate programmed cell death.

2021 ◽  
Vol 2021 (9) ◽  
Author(s):  
Hiroshi Kataoka ◽  
Daisuke Shimada ◽  
Hitoki Nanaura ◽  
Kazuma Sugie

ABSTRACT This case is the first document to describe a patient receiving anti-programmed cell death 1 (PD-1) antibodies which showed cranial dura matter involvement. According to the increasing use of anti-PD-1 monoclonal antibodies, adverse effects can occur in several organs since its ligand PD-L1 and PD-L2 are expressed in a wide variety of tissues. The estimated rate of neurological complications is 1–4.2% of patients, and neuromuscular disorders are the most common. Adverse effects on the central nervous system including encephalitis are less frequent. Here, a patient receiving anti-PD-1 antibodies showed cranial dura matter involvement, and the dura enhancement on MRI was resolved by withdrawal of the treatment with anti-PD-1 antibodies only.


FEBS Letters ◽  
2016 ◽  
Vol 590 (15) ◽  
pp. 2435-2453 ◽  
Author(s):  
Filipe Pinto-Teixeira ◽  
Nikolaos Konstantinides ◽  
Claude Desplan

2014 ◽  
Vol 50 (2) ◽  
pp. 463-472 ◽  
Author(s):  
Beatrice Macchi ◽  
Francesca Marino-Merlo ◽  
Caterina Frezza ◽  
Salvatore Cuzzocrea ◽  
Antonio Mastino

2006 ◽  
Vol 22 (3) ◽  
pp. 199-211 ◽  
Author(s):  
V. H. Casco ◽  
M. F. Izaguirre ◽  
L. Marín ◽  
M. N. Vergara ◽  
R. C. Lajmanovich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document